Oscar Health, Inc.
OSCRNYSEHealthcare● Active
$27.48
+$2.97(+12.10%)
Market Cap$7.1B
P/E Ratio—
52W High$27.46
52W Low$10.69
Oscar Health, Inc. (OSCR) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
OSCR · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
$2.07
Est. $1.21 · +71.1%
Revenue
$4.58B
Est. $4.89B · -6.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
OSCR reports quarterly as a NYSE-listed Medical - Healthcare Plans company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | $0.34 | — | — | — | $4.73B | — |
| ▲ Q2 FY2026 | May 6, 2026 | $1.21 | $2.07 | +71.1% | $4.58B | $4.89B | -6.4% |
| ▼ Q1 FY2026 | Feb 10, 2026 | -$0.92 | -$1.24 | -34.6% | $2.75B | $3.12B | -12.1% |
| ▲ Q4 FY2025 | Nov 6, 2025 | -$0.55 | -$0.53 | +3.6% | $2.99B | $3.05B | -2.2% |
| ▲ Q3 FY2025 | Aug 6, 2025 | -$0.90 | -$0.89 | +1.1% | $2.86B | $3.07B | -6.8% |
| ▲ Q2 FY2025 | May 7, 2025 | $0.83 | $0.92 | +10.8% | $3.05B | $2.78B | +9.6% |
| ▼ Q1 FY2025 | Feb 4, 2025 | -$0.55 | -$0.62 | -12.7% | $2.39B | $2.83B | -15.3% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -$0.20 | -$0.22 | -10.0% | $2.42B | $2.34B | +3.6% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
$0.34
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Beat
EPS Actual
$2.07
EPS Est.
$1.21
EPS Surpr.
+71.1%
Revenue
$4.58B
Q1 FY2026
Feb 10, 2026Miss
EPS Actual
-$1.24
EPS Est.
-$0.92
EPS Surpr.
-34.6%
Revenue
$2.75B
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
-$0.53
EPS Est.
-$0.55
EPS Surpr.
+3.6%
Revenue
$2.99B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
-$0.89
EPS Est.
-$0.90
EPS Surpr.
+1.1%
Revenue
$2.86B
Q2 FY2025
May 7, 2025Beat
EPS Actual
$0.92
EPS Est.
$0.83
EPS Surpr.
+10.8%
Revenue
$3.05B
Q1 FY2025
Feb 4, 2025Miss
EPS Actual
-$0.62
EPS Est.
-$0.55
EPS Surpr.
-12.7%
Revenue
$2.39B
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
-$0.22
EPS Est.
-$0.20
EPS Surpr.
-10.0%
Revenue
$2.42B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $-1.05 | $-0.99 | $-0.89 | 3 |
| Q3 FY2028 | $0.23 | $0.25 | $0.27 | 3 |
| Q2 FY2028 | $0.81 | $0.90 | $0.95 | 3 |
| Q1 FY2028 | $1.93 | $2.15 | $2.28 | 3 |
| Q4 FY2027 | $-1.26 | $-1.18 | $-1.06 | 2 |
| Q3 FY2027 | $-0.08 | $-0.07 | $-0.07 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $5.3B | $5.8B | $6.0B | 1 |
| Q3 FY2028 | $5.4B | $5.9B | $6.2B | 1 |
| Q2 FY2028 | $5.5B | $5.9B | $6.2B | 1 |
| Q1 FY2028 | $5.4B | $5.8B | $6.1B | 1 |
| Q4 FY2027 | $4.5B | $4.9B | $5.1B | 2 |
| Q3 FY2027 | $4.7B | $5.1B | $5.3B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 6, 2026 | +71.1% | $17.94 | $19.84 | +10.59% |
| ▼ Q1 FY2026 | Feb 10, 2026 | -34.6% | $12.66 | $12.88 | +1.74% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +3.6% | $17.03 | $16.56 | -2.76% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +1.1% | $13.82 | $14.34 | +3.76% |
| ▲ Q2 FY2025 | May 7, 2025 | +10.8% | $13.07 | $17.02 | +30.22% |
| ▼ Q1 FY2025 | Feb 4, 2025 | -12.7% | $16.75 | $15.28 | -8.78% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -10.0% | $15.55 | $13.64 | -12.28% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +25.0% | $17.23 | $16.70 | -3.08% |
Q2 FY2026+10.59%
Report Date
May 6, 2026
EPS Beat/Miss
+71.1%
Price Before
$17.94
Price After
$19.84
Q1 FY2026+1.74%
Report Date
Feb 10, 2026
EPS Beat/Miss
-34.6%
Price Before
$12.66
Price After
$12.88
Q4 FY2025-2.76%
Report Date
Nov 6, 2025
EPS Beat/Miss
+3.6%
Price Before
$17.03
Price After
$16.56
Q3 FY2025+3.76%
Report Date
Aug 6, 2025
EPS Beat/Miss
+1.1%
Price Before
$13.82
Price After
$14.34
Q2 FY2025+30.22%
Report Date
May 7, 2025
EPS Beat/Miss
+10.8%
Price Before
$13.07
Price After
$17.02
Q1 FY2025-8.78%
Report Date
Feb 4, 2025
EPS Beat/Miss
-12.7%
Price Before
$16.75
Price After
$15.28
Q4 FY2024-12.28%
Report Date
Nov 7, 2024
EPS Beat/Miss
-10.0%
Price Before
$15.55
Price After
$13.64
Q3 FY2024-3.08%
Report Date
Aug 7, 2024
EPS Beat/Miss
+25.0%
Price Before
$17.23
Price After
$16.70
Avg Beat Reaction+7.75%
Avg Miss Reaction-6.44%
Beat Rate5 / 8 quarters
Largest Move+30.22% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: OSCR ends December
Oscar Health, Inc. (OSCR) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $2.07 — beating the analyst consensus of $1.21 by +71.1%. The next OSCR earnings date is expected around September 1, 2026.
Each quarter, investors track OSCR earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OSCR revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
OSCR's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
OSCR earnings · 5 questionsOscar Health, Inc.'s next earnings report is expected around September 1, 2026. OSCR typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OSCR historically reports after market close (AMC).
OSCR earnings datewhen is OSCR earningsOSCR next earnings datewhen does OSCR report earningsOSCR earnings calendar
▸ Source: FMP · Oscar Health, Inc. SEC filings · US GAAP · Oscar Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026